Fox Business: Eli Lilly cuts Zepbound prices in competitive weight loss drug market battle Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ... Eli Lilly cuts Zepbound prices in competitive weight loss drug market battle CNBC: Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec.

Understanding the Context

1, cash-paying patients ... Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site Zepbound is a prescription drug used to help manage weight loss in certain adults. It can also be used to treat obstructive sleep apenea in adults who are obese. Weight loss with Zepbound may vary ...

Key Insights

Zepbound, which contains the active ingredient tirzepatide, has Food and Drug Administration (FDA) approval for the following: weight management in adults with obesity weight management in adults with ...